Literature DB >> 25753591

The Epidemiology of Nonsurgical Hypoparathyroidism in Denmark: A Nationwide Case Finding Study.

Line Underbjerg1, Tanja Sikjaer1, Leif Mosekilde1, Lars Rejnmark1.   

Abstract

Nonsurgical hypoparathyroidism (HypoPT) is a rare disorder most often caused by mutations in different genes. It is characterized by hypocalcaemia with inappropriately low PTH levels. Knowledge about this group of patients, including their mortality and morbidity, is very sparse. The aim was to identify all patients diagnosed with nonsurgical HypoPT in Denmark and assess their mortality and risk of complications. Through registers and review of individual patient hospital charts we identified all patients diagnosed with nonsurgical HypoPT in Denmark between 1977 and 2012. We assessed their mortality and morbidity by comparing them with a group of age- and gender-matched population-based controls. We identified a total of 180 patients with nonsurgical HypoPT among whom 123 (68%) were alive at the date of follow-up (prevalence of 2.3/100,000 inhabitants). Compared with controls, mortality was not increased, but patients had a significantly increased risk of renal insufficiency (hazard ratio [HR] 6.01), cardiovascular diseases (HR 1.91), neuropsychiatric complications (HR 2.45), infections (HR 1.94), seizures (HR 10.05), cataract (HR 4.21), and fractures at the upper extremities (HR 1.93). In contrast patients had significantly reduced risk of malignant diseases (HR 0.44). In conclusion, nonsurgical HypoPT is a rare disease associated with a number of complications that should be considered when taking care of these patients.
© 2015 American Society for Bone and Mineral Research.

Entities:  

Keywords:  EPIDEMIOLOGY; OTHER THERAPEUTICS; PARATHYROID-RELATED DISORDERS

Mesh:

Year:  2015        PMID: 25753591     DOI: 10.1002/jbmr.2501

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  49 in total

Review 1.  Hypoparathyroidism.

Authors:  John P Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  2020-06-01       Impact factor: 5.958

Review 2.  Fracture risk in hypoparathyroidism: a systematic review and meta-analysis.

Authors:  R Pal; S K Bhadada; S Mukherjee; M Banerjee; A Kumar
Journal:  Osteoporos Int       Date:  2021-05-22       Impact factor: 4.507

3.  Does PTH Replacement Therapy Improve Quality of Life in Patients With Chronic Hypoparathyroidism?

Authors:  Karen K Winer
Journal:  J Clin Endocrinol Metab       Date:  2018-07-01       Impact factor: 5.958

4.  Calcium, vitamin D or recombinant parathyroid hormone for managing post-thyroidectomy hypoparathyroidism.

Authors:  Ovie Edafe; Claudia E Mech; Sabapathy P Balasubramanian
Journal:  Cochrane Database Syst Rev       Date:  2019-05-22

Review 5.  Quality of life in patients with hypoparathyroidism receiving standard treatment: a systematic review.

Authors:  Matthias Büttner; Thomas J Musholt; Susanne Singer
Journal:  Endocrine       Date:  2017-08-18       Impact factor: 3.633

Review 6.  Ocular manifestations in celiac disease: an overview.

Authors:  Fotios S Fousekis; Andreas Katsanos; Konstantinos H Katsanos; Dimitrios K Christodoulou
Journal:  Int Ophthalmol       Date:  2020-01-08       Impact factor: 2.031

7.  Effects of Parathyroid Hormone Administration on Bone Strength in Hypoparathyroidism.

Authors:  Mishaela R Rubin; Alexander Zwahlen; David W Dempster; Hua Zhou; Natalie E Cusano; Chengchen Zhang; Ralph Müller; John P Bilezikian
Journal:  J Bone Miner Res       Date:  2016-01-24       Impact factor: 6.741

8.  PTH and bone material strength in hypoparathyroidism as measured by impact microindentation.

Authors:  J R Starr; G Tabacco; R Majeed; B Omeragic; L Bandeira; M R Rubin
Journal:  Osteoporos Int       Date:  2019-11-13       Impact factor: 4.507

Review 9.  Bone imaging in hypoparathyroidism.

Authors:  B C Silva; M R Rubin; N E Cusano; J P Bilezikian
Journal:  Osteoporos Int       Date:  2016-08-30       Impact factor: 4.507

10.  Changes in Skeletal Microstructure Through Four Continuous Years of rhPTH(1-84) Therapy in Hypoparathyroidism.

Authors:  Natalie E Cusano; Mishaela R Rubin; John M Williams; Sanchita Agarwal; Gaia Tabacco; Donovan Tay; Rukshana Majeed; Beatriz Omeragic; John P Bilezikian
Journal:  J Bone Miner Res       Date:  2020-03-26       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.